Clinical Trials

1. Key-Whitman’s commitment to clinical research enables our practice a prestigious opportunity to be in the forefront of ophthalmic technology. Clinical trials provide an exciting opportunity to our patients to potentially receive the latest technology in intraocular lens implant, medication delivery devices or advanced surgical procedures and often times the device or drug is provided to the patients at no cost. Key-Whitman Eye Center works closely with multiple sponsors and will only participate in clinical trials that we believe can benefit our patients. All of the clinical trials that are conducted at Key-Whitman are compliant with all FDA regulations. Clinical Research is an important aspect of medicine and Key-Whitman is proud to be involved with research and the positive impact that it can have on the ophthalmic community.

Current Clinical Trials:

Cataract

• Kowa KI-362-US3 - Avansee Preset IOL study
  1. You may qualify for this study if you meet the following - 
     1. Cataract in one or both eyes
     2. No history of eye surgery or major trauma
     3. No visually significant eye disease
   All follow up visits are covered for study participants that qualify. 

Glaucoma

• Glaukos GLK401-01 -  iStent Infinite study 
  1. You may qualify for this study if you meet the following: 
  2. Have a diagnosis of mild to moderate primary open angle glaucoma
  3. Are currently using 1-4 ocular hypotensive eyedrops for glaucoma management
  4. 35 years old or older 
  Cost of iStent implantation and all follow up visits are covered for study participants that qualify. 

Sign Up for Our Studies Below: